Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 4 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Nippon Shinyaku Co., Ltd. is managing 7 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 7 actions are distributed among 7 distinct examiners. The portfolio spans 4 distinct art units, indicating a concentration of technical focus within the biotechnology sector.
Rakesh Kumar is the busiest examiner with 1 pending office action. This structure shows that while the examiners are unique for each action, the technical review is concentrated in a small number of art units. For practitioners, the 7 distinct examiners for 7 pending office actions mean that each case requires a unique examiner interaction. The 4 distinct art units provide a level of technical clustering for the 7 pending matters within the USPTO's biotechnology divisions, which can help in coordinating the overall prosecution strategy for the portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (29%) |
| §103 only | 1 (14%) |
| §102 only | 2 (29%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUMAR, RAKESH | 1 | 57.2% | +28.2% |
| RILEY, JEZIA | 1 | 82.9% | +7.3% |
| KARUNASENA, ENUSHA | 1 | 0.0% | +0.0% |
| LEE, CHIHYI NMN | 1 | 33.7% | +60.8% |
| RYAN, DOUGLAS CHARLES | 1 | 39.2% | +47.6% |
| GALSTER, SAMUEL LEONARD | 1 | 50.9% | +43.2% |
| MCMILLIAN, KARA RENITA | 1 | 30.7% | +37.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723577 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | RILEY, JEZIA | — |
| 18685453 | METHOD FOR ESTIMATING MICROBIAL GROWTH RATE IN FOOD, METHOD FOR EVALUATING SHELF LIFE OF FOOD, AND SYSTEM FOR ESTIMATING MICROBIAL GROWTH RATE IN FOOD | KARUNASENA, ENUSHA | — |
| 18684158 | HEAT-RESISTANT MOLD GROWTH INHIBITOR, FOOD AND DRINK IN WHICH GROWTH OF HEAT-RESISTANT MOLD IS INHIBITED, AND METHOD FOR INHIBITING GROWTH OF HEAT-RESISTANT MOLD | LEE, CHIHYI NMN | — |
| 18577142 | PRECIPITATION SUPPRESSING AGENT | RYAN, DOUGLAS CHARLES | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18288057 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | GALSTER, SAMUEL LEONARD | 9d overdue |
| 18284941 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | MCMILLIAN, KARA RENITA | 41d |
| 19232346 | MEASURING CONTAINER | KUMAR, RAKESH | — |
| 18684158 | HEAT-RESISTANT MOLD GROWTH INHIBITOR, FOOD AND DRINK IN WHICH GROWTH OF HEAT-RESISTANT MOLD IS INHIBITED, AND METHOD FOR INHIBITING GROWTH OF HEAT-RESISTANT MOLD | LEE, CHIHYI NMN | — |
| 18577142 | PRECIPITATION SUPPRESSING AGENT | RYAN, DOUGLAS CHARLES | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1628 | 1 |
| 1693 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19232346 | MEASURING CONTAINER | KUMAR, RAKESH | — | §102 | Non-Final OA | — | Pending | Jun 09, 2025 |
| 18723577 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | RILEY, JEZIA | — | §102§103§112 | Non-Final OA | — | Pending | Jun 24, 2024 |
| 18685453 | METHOD FOR ESTIMATING MICROBIAL GROWTH RATE IN FOOD, METHOD FOR EVALUATING SHELF LIFE OF FOOD, AND SYSTEM FOR ESTIMATING MICROBIAL GROWTH RATE IN FOOD | KARUNASENA, ENUSHA | 1653 | §101§102 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18684158 | HEAT-RESISTANT MOLD GROWTH INHIBITOR, FOOD AND DRINK IN WHICH GROWTH OF HEAT-RESISTANT MOLD IS INHIBITED, AND METHOD FOR INHIBITING GROWTH OF HEAT-RESISTANT MOLD | LEE, CHIHYI NMN | 1628 | §101§102 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18577142 | PRECIPITATION SUPPRESSING AGENT | RYAN, DOUGLAS CHARLES | — | §102§103 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18288057 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | GALSTER, SAMUEL LEONARD | 1693 | §103 | Final Rejection | 9d overdue | Pending | Oct 24, 2023 |
| 18284941 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | MCMILLIAN, KARA RENITA | 1623 | §102Other | Non-Final OA | 41d | Pending | Sep 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial